Pharmaceuticals

AstraZeneca completes equity investment and research collaboration with Cellectis

bexib
By bexib 0 Min Read

The joint venture aims to develop up to 10 new cell and gene therapy products targeting areas of high unmet medical need.

You Might Also Like

APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology

Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins

New ways to determine drug value with health equity in mind

Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions

Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer

Share This Article
Previous Article 13 Website Usability Testing Tools
Next Article Exactly steel! Grab your freedom! Domestic product! The name of the horse running in the 2024 Kentucky Derby is correct.
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Stay Connected

Latest News

Data suggests a strong holiday season in 2024
Retail & E-commerce
Signicat uses AsiaVerify to strengthen identity verification in APAC
Fintech
Singapore Gulf Bank aims to raise up to $50 million to acquire stablecoin company
Fintech
Utrip raises Series C ahead of planned IPO, listing still ‘several years’ away
Fintech